Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer.
Lee IH, Lee SJ, Kim J, Lee YH, Chong GO, Kim JM, Lee J, Lee NY, Park SY, Hong DG, Chae YS.
Lee IH, et al. Among authors: lee sj, lee ny, lee j, lee yh.
Cancer Chemother Pharmacol. 2024 Apr 23. doi: 10.1007/s00280-024-04670-8. Online ahead of print.
Cancer Chemother Pharmacol. 2024.
PMID: 38652271